New - European Medical Journal

Continue

News

Allergy & Immunology
10 Apr 2025

How COVID-19 Increased Stress in Food Allergy Households

Mental health concerns were prevalent, with nearly all families experiencing stress.
Hematology
9 Apr 2025

EBMT 2025: Long-Term Outcomes of CAR-T Cell Therapy in Relapsed Lymphoma

A study at EBMT 2025 shows improved outcomes for relapsed lymphoma patients using CAR-T cell therapy with stem cell transplantation.
Hematology
9 Apr 2025

EBMT 2025: Stem Cell Treatment for Early-Onset IBD

HSCT shows promising results as a cure for very early-onset inflammatory bowel disease caused by IL-10 receptor deficiency.
Hepatology
9 Apr 2025

Targeting Senescent Cells to Treat MASLD Effectively

Recent studies have identified a gene signature known as the senescent hepatocyte gene signature that tracks with MASLD progression.
Hematology
9 Apr 2025

EBMT 2025: Transplantation Outcomes in MDS/AML

Explore EBMT 2025 results on transplantation outcomes for Myelodysplastic Syndrome and Acute Myeloid Leukaemia, highlighting survival and relapse data.
Hematology
9 Apr 2025

EBMT 2025: Adoptive Cell Therapy for Infections in Immunocompromised

Adoptive cell therapy with memory T lymphocytes clears infections in patients that are immunocompromised, showing promising results at EBMT 2025.
Hematology
9 Apr 2025

EBMT 2025: Are Functional Respiratory Tests Key for Screening in CAR-T Cell Therapy?

Functional respiratory tests may help predict outcomes in anti-CD19 CAR-T cell therapy, as shown in EBMT 2025 research.
Hematology
9 Apr 2025

EBMT 2025: Maintenance Therapy Improves High-Risk AML Outcomes

Maintenance therapy significantly boosts outcomes for high-risk AML patients after transplantation, as highlighted at EBMT 2025.
We’ve noticed you’re accessing
from North/South America.